James Healy

Companies

• Seaport Therapeutics, Inc.Board member Apr 30, 2026 to now¹
• BioAge Labs, Inc.Board member Sep 25, 2024 to now²
• Rapport Therapeutics, Inc.Board member Jun 6, 2024 to now³
• Y-mAbs Therapeutics, Inc.Board member Sep 20, 2018 to now⁴
• NateraBoard member Jul 1, 2015 to now⁵
• Bolt Biotherapeutics, Inc.Board member Feb 4, 2021 to Jun 14, 2024⁶
• Karuna TherapeuticsBoard member Jun 27, 2019 to Mar 18, 2024⁷
• ArriVent BioPharma, Inc.Board member Jan 25, 2024 to Jan 31, 2024⁸
• CinCor Pharma, Inc.Board member Jan 6, 2022 to Feb 27, 2023⁹
• Coherus BioSciences (United States)Board member Nov 6, 2014 to Feb 11, 2022¹⁰
• Iterum Therapeutics plcBoard member May 24, 2018 to Jan 23, 2020¹¹
• PDS Biotechnology CorpBoard member Sep 30, 2015 to Jun 21, 2017¹²
• Amarin CorporationBoard member Dec 30, 2010 to Jul 13, 2016¹³
• Anthera PharmaceuticalsBoard member Feb 23, 2010 to May 20, 2013¹⁴
• HUMANIGEN, INCBoard member Aug 10, 2012 to May 2, 2013¹⁵
• Paratek Pharmaceuticals, Inc.Board member May 9, 2006 to Mar 31, 2008¹⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Natera NTRA1,596,540 shares¹⁷$642.7M at $402.54Apr 29, 2025
• STSeaport Therapeutics, Inc. SPTX2,731,538 shares¹⁸$48.0M at $17.57May 4, 2026
• ABArriVent BioPharma, Inc. AVBP1,696,752 shares¹⁹$30.0M at $17.70Jan 30, 2024
• RTRapport Therapeutics, Inc. RAPP18,641 shares²⁰$534.1K at $28.65Jul 3, 2024
• BLBioAge Labs, Inc. BIOA26,497 shares²¹$131.0K at $4.95Sep 27, 2024
• YMY-mAbs Therapeutics, Inc.0 shares²²Sep 16, 2025
• KTKaruna Therapeutics KRTX0 shares²³Mar 18, 2024
• CPCinCor Pharma, Inc.0 shares²⁴Feb 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 4, 2026Converted 804,379 shares of Seaport Therapeutics, Inc.¹⁸
• May 4, 2026Converted 1,927,159 shares of Seaport Therapeutics, Inc.¹⁸
• Sep 16, 2025U 2,194,278 shares at $8.60 of Y-mAbs Therapeutics, Inc.²²
• Sep 16, 2025Returned to company 25,080 shares of Y-mAbs Therapeutics, Inc.²²
• Sep 16, 2025U 31,603 shares at $8.60 of Y-mAbs Therapeutics, Inc.²²
• Jun 30, 2025Granted 25,080 shares of Y-mAbs Therapeutics, Inc.²⁵
• Apr 25, 2025Granted 142 shares of Natera¹⁷
• Jan 31, 2025Granted 114 shares of Natera²⁶
• Oct 25, 2024Granted 153 shares of Natera²⁷
• Sep 27, 2024Bought 26,497 shares at $18.00 of BioAge Labs, Inc.²¹
• Sep 27, 2024Bought 21,814 shares at $18.00 of BioAge Labs, Inc.²¹
• Sep 27, 2024Bought 18,353 shares at $18.00 of BioAge Labs, Inc.²¹
• Sep 27, 2024Bought 11,113 shares at $18.00 of BioAge Labs, Inc.²¹
• Sep 27, 2024Bought 588,888 shares at $18.00 of BioAge Labs, Inc.²¹
• Sep 27, 2024Converted 1,638,236 shares of BioAge Labs, Inc.²¹
• Jul 26, 2024Granted 177 shares of Natera²⁸
• Jul 1, 2024Bought 2,625 shares at $26.06 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 4,661 shares at $25.02 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 3,657 shares at $24.21 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 3,630 shares at $23.08 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 2,748 shares at $26.06 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 4,878 shares at $25.02 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 3,828 shares at $24.21 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 3,799 shares at $23.08 of Rapport Therapeutics, Inc.²⁰
• Jul 1, 2024Bought 2,559 shares at $26.06 of Rapport Therapeutics, Inc.²⁰